Pharma Capital
Showing 40 of 940
Name Market Market Cap Share Price Daily Share Movement
1300 SMILES LIMITED ASX £91.22m £4.28 -0.42% ico_glass.png
1ST DENTAL LABS PRIVATE £- £- - ico_glass.png
4D Pharma AIM £159.55m £2.46 -2.57% ico_glass.png
Abbvie NYSE £85,359.10m £53.63 -1.80% ico_glass.png
Abeona Therapeutics NASDAQ £- £- - ico_glass.png
ABIOMED NASDAQ £- £- - ico_glass.png
abzena-logo.png Abzena plc AIM £105.75m £0.50 0.00% ico_glass.png
Acceleron Pharma Inc NASDAQ £- £- - ico_glass.png
Accelrys NASDAQ £- £- - ico_glass.png
Accurexa OTCBB £- £- - ico_glass.png
AcelRx Pharmaceuticals NASDAQ £- £- - ico_glass.png
Acer Therapeutics PRIVATE £- £- - ico_glass.png
Achaogen NASDAQ £- £- - ico_glass.png
Achillion Pharmaceuticals NASDAQ £- £- - ico_glass.png
Acrux ASX £31.39m £0.19 0.00% ico_glass.png
Actinogen Medical ASX £22.25m £0.04 -1.67% ico_glass.png
Adherium ASX £15.15m £0.09 11.54% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £40.29m £0.16 1.96% ico_glass.png
Advanced Medical Solutions Group AIM £626.81m £2.96 -1.42% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £12.75m £0.16 0.00% ico_glass.png
Advanced Surgical Design & Manufacturing ASX £7.02m £0.09 -17.65% ico_glass.png
Advantis Corporation OTC £- £- - ico_glass.png
Aequus Pharmaceuticals Inc TSX-V £8.49m £0.12 -4.88% ico_glass.png
Aetna NYSE £39,219.50m £118.24 0.90% ico_glass.png
Affymax NASDAQ £- £- - ico_glass.png
AFP Imaging OTCMKTS £- £- - ico_glass.png
Agenix Limited ASX £- £- - ico_glass.png
Agenus NASDAQ £- £- - ico_glass.png
Agility Health TSX-V £7.12m £0.06 12.50% ico_glass.png
Agios Pharmaceuticals NASDAQ £- £- - ico_glass.png
AGTC NASDAQ £- £- - ico_glass.png
Ainsworth Lumber TSX £- £- 0.00% ico_glass.png
AirXpanders ASX £40.82m £0.43 -2.78% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £7.34m £0.83 -5.71% ico_glass.png
Akorn NASDAQ £- £- - ico_glass.png
Alchemia ASX £1.98m £0.01 11.11% ico_glass.png
Alcidion Group ASX £24.39m £0.04 -4.35% ico_glass.png
Alda Pharmaceuticals TSX-V £- £- - ico_glass.png
ALEGRO HEALTH CORP TSX-V £0.92m £0.01 0.00% ico_glass.png
Alere NYSE £3,361.38m £38.47 0.04% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.